E
TECH icon

Ergoteles’s Bio-Techne TECH Stock Holding History

Ergoteles’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,102
Closed -$1.19M – 1517
2023
Q1 		$1.19M Buy
+16,102
New +$1.24M 0.05% 432
2022
Q4 		– Sell
-12,844
Closed -$912K – 1873
2022
Q3 		$912K Buy
12,844
+7,232
+129% +$625K 0.03% 519
2022
Q2 		$486K Buy
+5,612
New +$526K 0.01% 849
2021
Q4 		– Sell
-118,252
Closed -$14.3M – 1586
2021
Q3 		$14.3M Buy
+118,252
New +$14.4M 0.52% 39
2021
Q2 		– Sell
-122,424
Closed -$11.7M – 1687
2021
Q1 		$11.7M Buy
122,424
+66,024
+117% +$6.02M 0.36% 71
2020
Q4 		$4.48M Buy
+56,400
New +$4.08M 0.15% 156

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Ergoteles's TECH Position: Q2 2023 in Review

Ergoteles sold out of Bio-Techne (TECH) in Q2 2023, closing a stake of 16,102 shares — an estimated $1.19M sold.

Ergoteles first reported a position in TECH in Q4 2020 and held it in 6 quarters. The position peaked at $14.3M in Q3 2021. 529 funds tracked by Wall St. Rank hold TECH as of Q2 2023.

  • Ergoteles reported no remaining Bio-Techne position as of Q2 2023 after selling out during the quarter.
  • Ergoteles sold 16,102 Bio-Techne shares in Q2 2023, an estimated $1.19M.
  • Ergoteles first reported a position in Bio-Techne in Q4 2020 and held it in 6 quarters.
  • Ergoteles's Bio-Techne position peaked at $14.3M in Q3 2021.
  • 529 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.